This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Aventis Pharmaceuticals Inc., Hoechst Marion Roussel, Hoechst Roussel Pharmaceuticals. Active years: 1994-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 207 
1 out of 236 
1 out of 539 
Years Active: 1994-2017
Title: The Innovative Contributions of Sathapana Kongsamut
Introduction
Sathapana Kongsamut is a notable inventor based in Madison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lipid storage disorders and central nervous system disorders. With a total of 5 patents to his name, Kongsamut's work has the potential to impact various medical conditions.
Latest Patents
Kongsamut's latest patents include innovative methods and compositions for the treatment of lipid storage disorders. This involves treating subjects with a composition that comprises a PKC activator, such as bryostatins, bryologs, and polyunsaturated fatty acids. Another significant patent focuses on substituted dihydro and tetrahydro oxazolopyrimidinones. This invention relates to a series of compounds that are modulators of metabotropic glutamate receptors, particularly the mGluR2 receptor. These compounds are useful as pharmaceutical agents in treating a variety of central nervous system disorders, including neurodegenerative conditions, psychoses, anxiety, and sleep disorders.
Career Highlights
Throughout his career, Sathapana Kongsamut has worked with prominent organizations such as Aventis Pharmaceuticals Inc. and the Icahn School of Medicine at Mount Sinai. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Kongsamut has collaborated with notable colleagues, including Craig P. Smith and Gary Emmons. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing his contributions to the field.
Conclusion
Sathapana Kongsamut's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving medical treatments and addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile